Addition of alpha-adrenergic agonists to TPA formulary
Action 5622 / Stage 9112
Final Stage
| Status |
|
Changes to Text
|
No changes have been made to the text since the proposed stage was last published in the Register.
|
| Attorney General Review |
Submitted to OAG: 10/21/2020
Review Completed: 10/30/2020
Result: Certified
|
| Virginia Registrar |
Submitted on 11/2/2020
The Virginia Register of Regulations
Publication Date: 11/23/2020
Volume: 37 Issue: 7
|
|
Comment Period
|
No comment period held for this exempt action/stage.
|
|
Effective Date
|
12/9/2020
|
| Contact Information |
|
Name / Title:
|
Kelli Moss
/
Executive Director
|
|
Address:
|
9960 Mayland Drive
Suite 300
Henrico, VA 23233
|
|
Email Address:
|
kelli.moss@dhp.virginia.gov
|
|
Telephone:
|
(804)597-4077
FAX: (804)793-9145
TDD: ()-
|
This person is the primary contact for this board.
X
close window
Action 5622:
Addition of alpha-adrenergic agonists to TPA formulary
Stages associated with this regulatory action.
| Stage Type |
Status |
|
Proposed
(9092)
|
Stage complete. No comment period held.
|
|
Final
(9112)
|
Stage complete. This regulation became effective on 12/09/2020.
|
X
close window
Place On Hold Pending External Action
Enter a reason up to 300 characters. Will be viewable only on the Governor's Pending List.
A stage can be placed "On Hold" only once. When there are major issues with a stage, please consider
asking the agency to withdraw the stage and submit a new stage when it is ready for review.
Final Text
Agency Background Document
